Standardization of pulmonary diffusing capacity for nitric oxide

G. Zavorsky (Atlanta, United States of America)

Source: International Congress 2017 – ERS statements and technical standards on diagnosis and monitoring
Session: ERS statements and technical standards on diagnosis and monitoring
Session type: Session
Number: 1460

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Zavorsky (Atlanta, United States of America). Standardization of pulmonary diffusing capacity for nitric oxide. International Congress 2017 – ERS statements and technical standards on diagnosis and monitoring

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A small amount of inhaled nitric oxide does not increase lung diffusing capacity
Source: Eur Respir J 2006; 27: 1251-1257
Year: 2006



Early detection of emphysema with the nitric oxide diffusion capacity
Source: Eur Respir J 2007; 30: Suppl. 51, 8s
Year: 2007

Standardisation and application of the single-breath determination of nitric oxide uptake in the lung
Source: Eur Respir J , 49 (2) 1600962; DOI: 10.1183/13993003.00962-2016
Year: 2017




Fractional exhaled nitric oxide in pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016

Standardisation and application of the single-breath determination of nitric oxide uptake in the lung
Source: Guideline 2017
Year: 2017

Reference equations for pulmonary diffusing capacity of carbon monoxide and nitric oxide in adult Caucasians
Source: Eur Respir J, 52 (1) 1500677; 10.1183/13993003.00677-2015
Year: 2018



The nitric oxide diffusing capacity strongly depends on alveolar volume
Source: Eur Respir J 2005; 26: Suppl. 49, 262s
Year: 2005

Exhaled nitric oxide in reactive pulmonary hypertenzion
Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models
Year: 2012

An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis
Source: Eur Respir J 2004; 24 : 609-614
Year: 2004



Diffusing capacity of the lung for nitric oxide and carbon monoxide: Influence of alveolar volume
Source: Annual Congress 2010 - Advances in lung function I
Year: 2010

Reduced bronchial nitric oxide flux but unchanged alveolar nitric oxide concentration after exposure to hyperbaric hyperoxia
Source: Annual Congress 2010 - New diagnostic approaches in respiratory function
Year: 2010


Fractional exhaled nitric oxide in bronchiectasis
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012


Measurement of exhaled nitric oxide in patients with pulmonary tuberculosis
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013

Clinical correlates of alveolar nitric oxide in COPD
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018

Lung diffusing capacity for nitric oxide and carbon monoxide: methodological issues and reproducibility in patients with cystic fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 325s
Year: 2007

Exhaled nitric oxide values measured at 10ml/s influence assessments of bronchial nitric oxide flux
Source: Eur Respir J 2006; 28: Suppl. 50, 792s
Year: 2006

Measurement of exhaled nitric oxide in children
Source: Guideline 2002
Year: 2002

Inhaled nitric oxide (NO) for vasoreactivity testing in pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 584s
Year: 2003

Using a membrane oxygenator for simultaneous measurement of nitric oxide and carbon monoxide diffusing capacity
Source: Eur Respir J 2003; 22: Suppl. 45, 86s
Year: 2003